LENNON DAVID JAMES (CHIEF EXECUTIVE OFFICER) sold 29.8% of their position (9.69K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $18.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/3/2024ACC: 0001415889-24-024676
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
-9.69K
Net shares
Net seller
$18.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
32.56K acquired · 42.25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+32.56K
Price / share
—
Trade value
—
% of position
New position
10/2/2024
0.00→32.56K
Common Stock
Direct
Shares
−9.69K
Price / share
$1.94
Trade value
$18.80K
% of position
29.8%
10/3/2024
32.56K→22.87K
Total
Net shares
+22.87K
Net value
-$18.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2024 | M · Option Exercise | +32.56K | — | — | New position | 0.00 | 32.56K |
| Common Stock Direct | 10/3/2024 | S · Sale | −9.69K | $1.94 | $18.80K | 29.8% | 32.56K | 22.87K |
| Total | +22.87K | -$18.80K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
32.56K shares
Shares
−32.56K
Strike price
Held after
0.00
Exercisable
—
10/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock32.56K shares | 10/2/2024 | M · Option Exercise | −32.56K | — | 0.00 |